Director Henderson Jeffrey William 🟢 acquired 9.8K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $65.87 Transaction Date: May 05, 2026 | Filing ID: 000061
Langston Patrick Ryan 🟢 acquired 7.0K shares (1 derivative) of Goosehead Insurance, Inc. (GSHD) at $42.46 Transaction Date: May 05, 2026 | Filing ID: 000001
Director DUNCAN BARBARA GAYLE 🟢 acquired 9.8K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $65.87 Transaction Date: May 05, 2026 | Filing ID: 000060
Director Connaughton Bernadette 🟢 acquired 12.8K shares (1 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $65.87 Transaction Date: May 05, 2026 | Filing ID: 000059
Director Mehta Vimal 🟡 adjusted position in 0 shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: May 01, 2026 | Filing ID: 057367
Steinhart Richard I 🟡 adjusted position in 0 shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: May 01, 2026 | Filing ID: 057366
Rodriguez Javier 🟡 adjusted position in 0 shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) Transaction Date: May 01, 2026 | Filing ID: 057364
Director Cruzado Waded 🟢 acquired 14.0K shares (1 derivative) of Goosehead Insurance, Inc. (GSHD) at $42.46 Transaction Date: May 05, 2026 | Filing ID: 000001